Glen Harbor Capital Management LLC Has $28.27 Million Stake in CME Group (CME)

Glen Harbor Capital Management LLC cut its stake in CME Group (NASDAQ:CME) by 7.9% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 174,768 shares of the financial services provider’s stock after selling 14,982 shares during the period. Glen Harbor Capital Management LLC’s holdings in CME Group were worth $28,267,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently bought and sold shares of the company. Ontario Teachers Pension Plan Board lifted its holdings in CME Group by 12.4% in the fourth quarter. Ontario Teachers Pension Plan Board now owns 81,393 shares of the financial services provider’s stock valued at $11,887,000 after acquiring an additional 8,991 shares during the last quarter. Honeywell International Inc. acquired a new position in CME Group in the fourth quarter valued at approximately $35,052,000. LPL Financial LLC lifted its holdings in CME Group by 9.0% in the fourth quarter. LPL Financial LLC now owns 22,193 shares of the financial services provider’s stock valued at $3,241,000 after acquiring an additional 1,841 shares during the last quarter. Capital Advisors Inc. OK lifted its holdings in CME Group by 5.5% in the fourth quarter. Capital Advisors Inc. OK now owns 88,822 shares of the financial services provider’s stock valued at $12,972,000 after acquiring an additional 4,592 shares during the last quarter. Finally, Cornerstone Capital Management Holdings LLC. lifted its holdings in CME Group by 7.3% in the fourth quarter. Cornerstone Capital Management Holdings LLC. now owns 73,571 shares of the financial services provider’s stock valued at $10,744,000 after acquiring an additional 5,002 shares during the last quarter. Institutional investors and hedge funds own 82.12% of the company’s stock.

CME has been the topic of a number of recent analyst reports. ValuEngine upgraded CME Group from a “hold” rating to a “buy” rating in a report on Monday, April 2nd. Goldman Sachs upgraded CME Group from a “neutral” rating to a “buy” rating and set a $180.00 price objective on the stock in a report on Wednesday, February 7th. BidaskClub cut CME Group from a “strong-buy” rating to a “buy” rating in a report on Thursday, March 15th. Bank of America upped their price objective on CME Group from $175.00 to $185.00 and gave the company a “buy” rating in a report on Thursday, March 8th. Finally, Sandler O’Neill reiterated a “buy” rating and issued a $175.00 price objective on shares of CME Group in a report on Friday, February 2nd. Three equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. CME Group has a consensus rating of “Buy” and a consensus price target of $165.57.

CME Group opened at $159.78 on Monday, MarketBeat.com reports. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.04 and a current ratio of 1.04. CME Group has a 52 week low of $115.43 and a 52 week high of $171.71. The firm has a market cap of $54.24 billion, a price-to-earnings ratio of 29.59, a PEG ratio of 2.24 and a beta of 0.57.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Thursday, April 26th. The financial services provider reported $1.86 EPS for the quarter, topping analysts’ consensus estimates of $1.85 by $0.01. CME Group had a return on equity of 8.48% and a net margin of 111.45%. The company had revenue of $1.10 billion for the quarter, compared to analysts’ expectations of $1.12 billion. During the same period in the prior year, the firm earned $1.22 earnings per share. The firm’s revenue was up 18.4% compared to the same quarter last year. analysts anticipate that CME Group will post 6.79 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Monday, June 25th. Shareholders of record on Friday, June 8th will be paid a dividend of $0.70 per share. This represents a $2.80 dividend on an annualized basis and a yield of 1.75%. The ex-dividend date is Thursday, June 7th. CME Group’s dividend payout ratio (DPR) is 58.70%.

In other news, CFO John W. Pietrowicz sold 2,500 shares of the stock in a transaction on Tuesday, April 10th. The stock was sold at an average price of $161.02, for a total value of $402,550.00. Following the sale, the chief financial officer now directly owns 34,957 shares in the company, valued at $5,628,776.14. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Hilda Harris Piell sold 3,299 shares of the stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $163.52, for a total value of $539,452.48. The disclosure for this sale can be found here. 0.45% of the stock is owned by corporate insiders.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.




Leave a Reply